Nariz, Rhea Jane I.
HRN: 27-77-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/08/2025
CEFUROXIME 750MG (VIAL)
09/08/2025
09/14/2025
IVT
750mg
Q8H
UTI
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines